Asieris Pharmaceuticals (688176) is a prominent global biopharmaceutical firm specializing in the research, development, and commercialization of novel drugs targeting genitourinary tumors and related ailments.

Antengene Corporation Limited (SEHK: 6996.HK), a prominent global biopharmaceutical company focused on innovative therapies in hematology and oncology

Rising Pharmaceuticals, a subsidiary of Rising Pharma Holdings Inc., has announced the approval, launch, and immediate availability of Edetate calcium disodium injection, addressing a critical shortage of this vital therapy in the United States.

Brenntag, a prominent global player in the distribution of chemicals and ingredients, has announced a strategic collaboration with audit provider Qualifyze.

Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), a pioneering clinical stage biopharmaceutical company dedicated to advancing innovative treatments for brain health disorders, has announced a strategic license agreement with Catalent

Roche today announced the expansion of their Global Business Partnership Agreement with Sysmex. As part of the renewed framework, the companies strengthen their commitment

NeuroBo Pharmaceuticals, Inc. a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced that it has entered into a term sheet with MThera

Tyra Biosciences, Inc.a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor

Alpenglow Biosciences has been awarded a $1.6M grant to develop artificial intelligence (AI) enabled smart microscopy using its patented multi-resolution 3Di platform for 3D spatial biology.

Harrow a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application for VIGAMOX® 0.5%, a fluoroquinolone antibiotic